You searched for "population"
Instrument assessment preferable over standard beside swallow to determine prevalence of aspiration
Aspiration does not trigger the protective cough response in some patients. The patient’s response may vary according to fluid viscosities and volume. The authors of this prospective study investigated the prevalence of aspiration and response to aspiration of different viscosities...In conversation with Professor Valerie J Lund CBE
Valerie Lund is Professor of Rhinology at the Ear Institute, University College London and is an Honorary Consultant ENT Surgeon at the Royal National Throat Nose and Ear Hospital (Royal Free Trust), Moorfields Eye Hospital, University College Hospital and Imperial...ENT UK Northern ST3 Accelerated Learning Course Bootcamp 2023
Atia Khan (left), ENT Registrar, Royal Preston Hospital, North-West Trainee and Mr Raad John Glore (right), Consultant at Bradford Royal Infirmary. The transition from a core surgical trainee to a newly appointed specialist otolaryngology trainee can seem like a Herculean...
COVID-19 in patients with chronic rhinosinusitis with polyps. Are they at risk?
COVID-19 entry factors are highly present in nasal epithelial cells. These factors include ACE2 and TMPRSS2. Their presence in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) was not investigated before. Authors investigated expression of ACE2 and TMPRSS2 in two...
Lipofilling for scar improvement
Since Coleman et al. in 1991 reported on lipofilling, numerous applications have been reported; these include but are not limited to contour restoration, lip augmentation, and wrinkle therapy. There has also been some one off reported improvements in scars following...Management of olfactory dysfunction
An evidence-based update on olfactory dysfunction: who to image, how to test and what works – OT, CRS surgery, biologics and PRP. Olfactory dysfunction (OD) is highly prevalent, affecting more than 20% of the adult population with a clear age-related...Neuromod publishes results of second large-scale clinical trial for tinnitus, shows greater improvement of symptoms
Neuromod Devices, the medical device company specialising in tinnitus, has published the results of its TENT-A2 (Treatment Evaluation of Neuromodulation for Tinnitus – Stage A2) clinical trial in the scientific journal, Nature – Scientific Reports in a paper titled ‘Different bimodal neuromodulation settings reduce tinnitus symptoms in a large randomized trial’.
